G Darling
Overview
Explore the profile of G Darling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blitz M, Butts C, Kneteman N, Bigam D, Oosthuizen J, Phang P, et al.
Can J Surg
. 2023 Jun;
45(Suppl 3):3-26.
PMID: 37381180
No abstract available.
2.
Devon K, Vergara O, Victor J, Swallow C, Cohen Z, MacRae H, et al.
Can J Surg
. 2023 Jun;
50(Suppl 1):1-32.
PMID: 37353894
No abstract available.
3.
Nenshi R, Kennedy E, Saskin R, Vassiliou M, Fayez R, Krajewski S, et al.
Can J Surg
. 2022 Apr;
52(Suppl):S1-S48.
PMID: 35488397
No abstract available.
4.
Atlas H, Safa N, Denis R, Garneau P, Marceau S, Lebel S, et al.
Can J Surg
. 2022 Apr;
53(4):S51-S104.
PMID: 35488396
No abstract available.
5.
Bodie G, Hagen J, Almamar A, Majumdar S, Wang X, Tuepah R, et al.
Can J Surg
. 2022 Apr;
55(4 Suppl 1):S63-S135.
PMID: 35488395
No abstract available.
6.
Droeser R, Kaneva P, Cheng V, Lam L, Benjamin E, Matsushima K, et al.
Can J Surg
. 2022 Apr;
61(4 Suppl 1):S94-S174.
PMID: 35488393
No abstract available.
7.
Unger B, Gillman L, Hickey K, Pace D, Lam-Tin-Cheung K, Catton J, et al.
Can J Surg
. 2022 Apr;
64(6 Suppl 2):S80-S159.
PMID: 35483046
No abstract available.
8.
Sun A, Durocher-Allen L, Ellis P, Ung Y, Goffin J, Ramchandar K, et al.
Curr Oncol
. 2019 Jul;
26(3):e372-e384.
PMID: 31285682
Background: Patients with limited-stage (ls) or extensive-stage (es) small-cell lung cancer (sclc) are commonly given platinum-based chemotherapy as first-line treatment. Standard chemotherapy for patients with ls sclc includes a platinum...
9.
Keech J, Beca J, Eisen A, Kennedy E, Kim J, Kouroukis C, et al.
Curr Oncol
. 2019 May;
26(2):e155-e161.
PMID: 31043821
Background: In Canada, requests for public reimbursement of cancer drugs are predominately initiated by pharmaceutical manufacturers. Clinician-led submissions provide a mechanism to initiate the drug funding process when industry does...
10.
Natori A, Chan B, Sim H, Ma L, Yokom D, Chen E, et al.
Curr Oncol
. 2019 Jan;
25(6):366-370.
PMID: 30607110
Background: We aimed to assess current treatment patterns and outcomes in elderly patients with localized gastric and esophageal (ge) cancers. Methods: This retrospective analysis considered patients 75 years of age...